Topic resource collection
Approved comparison material connected to this topic.
7 resourcesRead both sides
Growth Hormone Secretagogues GHRP-2, CJC-1295, MK-677 Ghrelin receptor / GHRH receptor agonism → GH release Yes 4–6 hours recommended Clean stack. No receptor overlap, distinct biological endpoints Mitochondrial Peptides MOTS-C, …
KPV + BPC-157 NF-κB inhibition + VEGF upregulation and FAK-paxillin activation KPV 500mcg AM, BPC-157 250–500mcg PM, both subcutaneous daily Inflammatory bowel disease, gastric ulcers, joint inflammation, post-surgical healing No…
Recovery Peptides (BPC-157, TB-500) VEGF activation, actin polymerization None. Targets tissue repair, not collagen synthesis Yes No strict timing needed; can dose same day Synergistic when collagen substrate is available. Enhanc…
VIP + BPC-157 Moderate (cAMP pathway) 4 hours minimum High. Pathways reinforce Gut-brain axis inflammation, autoimmune protocols Synergistic if timed correctly; BPC-157's tissue repair complements VIP's immune modulation VIP + Th…
Cartalax + CJC-1295/Ipamorelin None. Thymic regulation vs GH secretagogue receptor High. Pair short-acting Cartalax with pulsatile GH release Cartalax AM, CJC/Ipa PM (8–12 hours apart) Mechanistically compatible; thymic support c…
GH Secretagogue (MK 677) Elevates pulsatile GH and IGF-1 to accelerate protein synthesis Hypertrophy blocks or high-volume phases 60–90 min before sleep, 3–4x weekly Muscular tissue repair Most effective when sleep quality is alr…
Choosing the wrong reconstitution solvent doesn't just reduce peptide lifespan. It can render the compound inactive before the first injection. Here's how BAC water for mixing peptides compares to the alternatives researchers com…